Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ISOFLURANE Cause Hyperthermia malignant? 87 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Hyperthermia malignant have been filed in association with ISOFLURANE (Isoflurane). This represents 10.5% of all adverse event reports for ISOFLURANE.

87
Reports of Hyperthermia malignant with ISOFLURANE
10.5%
of all ISOFLURANE reports
19
Deaths
43
Hospitalizations

How Dangerous Is Hyperthermia malignant From ISOFLURANE?

Of the 87 reports, 19 (21.8%) resulted in death, 43 (49.4%) required hospitalization, and 36 (41.4%) were considered life-threatening.

Is Hyperthermia malignant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ISOFLURANE. However, 87 reports have been filed with the FAERS database.

What Other Side Effects Does ISOFLURANE Cause?

Drug ineffective (134) Hypotension (127) Off label use (90) Intestinal ischaemia (77) Status epilepticus (75) Systemic inflammatory response syndrome (63) Necrosis ischaemic (56) Post procedural complication (55) Metabolic acidosis (54) Blood creatine phosphokinase increased (52)

What Other Drugs Cause Hyperthermia malignant?

SUCCINYLCHOLINE (276) SEVOFLURANE (207) PROPOFOL (205) FORANE (170) ROCURONIUM (114) FENTANYL (107) SEVOFLURANE, USP (93) MIDAZOLAM (62) CISATRACURIUM (60) SUFENTANIL (56)

Which ISOFLURANE Alternatives Have Lower Hyperthermia malignant Risk?

ISOFLURANE vs ISONIAZID ISOFLURANE vs ISONIAZID\PYRAZINAMIDE\RIFAMPIN ISOFLURANE vs ISONIAZID\PYRIDOXINE\SULFAMETHOXAZOLE\TRIMETHOPRIM ISOFLURANE vs ISONIAZID\RIFAMPIN ISOFLURANE vs ISOPROPANOLAMINE

Related Pages

ISOFLURANE Full Profile All Hyperthermia malignant Reports All Drugs Causing Hyperthermia malignant ISOFLURANE Demographics